Journal: Gut
Article Title: The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
doi: 10.1136/gut.2007.143941
Figure Lengend Snippet: Stimulation of the chemokine receptor CXCR4 leads to increased proliferation of pancreatic intraepithelial neoplasias (PanIN) in vitro which is abrogated by concominant MEK1/2 inhibition. (A) Alamar blue proliferation assays were performed in PanIN cells with increasing concentration of the CXCR4 ligand, CXCL12. Fluorescence measurements were performed at baseline as well as 12, 24, 48 and 72 h post-CXCL12 administration. PanIN cells demonstrated a dose-dependent increase in proliferation with CXCL12 administration compared to control and was statistically significant for all concentrations at all time points (p<0.05) with a 47% difference in fluorescence at 72 h between PanIN stimulated with 250 ng/ml CXCL12 and untreated control. (B) Pre- and concomitant incubation of the PanIN cells with the CXCR4 specific inhibitor AMD3100 abrogated the increased proliferation seen with CXCL12 administration alone. (C) Further decrease in proliferation when PanIN cells were co-incubated with the MEK1/2 inhibitor U0126. (D) Incubation with AMD3100 and U0126 was similar to U0126 alone, indicating that CXCL12 mediated PanIN proliferation is mitogen-activated protein kinase (MAPK) dependent.
Article Snippet: The sections were incubated at 4°C with a polyclonal anti-CXCR4 antibody (Abcam, Cambridge, Massachusetts, USA) at 1:50 dilution for 60 min and with a polyclonal anti-SDF-1a (CXCL12) antibody (US Biological, Swampscott, Massachusetts, USA) at 1:200 dilution for 30 min. Then, the sections were labelled with a secondary antibody (Envision+; Dako, Carpinteria, California, USA), developed with diaminobenzidine (DAB), counterstained in 50% Mayer’s haematoxylin and examined at ×200 and ×400 magnifications.
Techniques: In Vitro, Inhibition, Concentration Assay, Fluorescence, Control, Incubation